Market Cap | ₹48,391Cr |
ROE | 4.68% |
P/E Ratio(TTM) | 125.68 |
EPS(TTM) | 2.88 |
P/B Ratio | 1.85 |
Dividend Yield | 0.12% |
Industry P/E | 35.77 |
Book Value | 195.54 |
Debt to Equity | 0.85 |
Face Value | 5 |
Parent Organisation | Biocon Limited |
Managing Director | Mr. Siddharth Mittal |
NSE Symbol | BIOCON |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Anthem Biosciences | NA (0.00%) | 103.25 | ||
Onesource Specialty Pharma | NA (0.00%) | 302.92 | ||
Advanced Enzyme Technologies | NA (0.00%) | 27.63 | ||
Panacea Biotec | NA (0.00%) | 218.40 |